Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions

Murray J. Casey, Richard O'Brien, Marc Rendell, Todd A. Salzman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Catholic Church proscribes methods of birth control other than sexual abstinence. Although the U.S. Food and Drug Administration (FDA) recognizes abstinence as an acceptable method of birth control in research studies, some pharmaceutical companies mandate the use of artificial contraceptive techniques to avoid pregnancy as a condition for participation in their studies. These requirements are unacceptable at Catholic health care institutions, leading to conflicts among institutional review boards, clinical investigators, and sponsors. Subjects may feel coerced by such mandates to adopt contraceptive techniques inconsistent with their personal situation and beliefs; women committed to celibacy or who engage exclusively in non-heterosexual activities are negatively impacted. We propose principles to insure informed consent to safeguard the rights of research subjects at Catholic institutions while mitigating this ethical conflict. At the same time, our proposal respects the interests of pharmaceutical research agencies and Catholic moral precepts, and fully abides by regulatory guidance.

Original languageEnglish
Pages (from-to)34-37
Number of pages4
JournalAmerican Journal of Bioethics
Volume12
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Sexual Abstinence
Contraceptive Agents
Contraception
Research Subjects
Research Ethics Committees
United States Food and Drug Administration
Informed Consent
Research Personnel
Delivery of Health Care
Pregnancy
Research
Pharmaceutical Preparations
Pharmaceutical Research
Conflict (Psychology)

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Issues, ethics and legal aspects

Cite this

Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions. / Casey, Murray J.; O'Brien, Richard; Rendell, Marc; Salzman, Todd A.

In: American Journal of Bioethics, Vol. 12, No. 7, 07.2012, p. 34-37.

Research output: Contribution to journalArticle

@article{19aa8e7cda004e2ca0b5b0b7aad9826e,
title = "Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions",
abstract = "The Catholic Church proscribes methods of birth control other than sexual abstinence. Although the U.S. Food and Drug Administration (FDA) recognizes abstinence as an acceptable method of birth control in research studies, some pharmaceutical companies mandate the use of artificial contraceptive techniques to avoid pregnancy as a condition for participation in their studies. These requirements are unacceptable at Catholic health care institutions, leading to conflicts among institutional review boards, clinical investigators, and sponsors. Subjects may feel coerced by such mandates to adopt contraceptive techniques inconsistent with their personal situation and beliefs; women committed to celibacy or who engage exclusively in non-heterosexual activities are negatively impacted. We propose principles to insure informed consent to safeguard the rights of research subjects at Catholic institutions while mitigating this ethical conflict. At the same time, our proposal respects the interests of pharmaceutical research agencies and Catholic moral precepts, and fully abides by regulatory guidance.",
author = "Casey, {Murray J.} and Richard O'Brien and Marc Rendell and Salzman, {Todd A.}",
year = "2012",
month = "7",
doi = "10.1080/15265161.2012.680532",
language = "English",
volume = "12",
pages = "34--37",
journal = "American Journal of Bioethics",
issn = "1526-5161",
publisher = "Routledge",
number = "7",

}

TY - JOUR

T1 - Ethical Dilemma of Mandated Contraception in Pharmaceutical Research at Catholic Medical Institutions

AU - Casey, Murray J.

AU - O'Brien, Richard

AU - Rendell, Marc

AU - Salzman, Todd A.

PY - 2012/7

Y1 - 2012/7

N2 - The Catholic Church proscribes methods of birth control other than sexual abstinence. Although the U.S. Food and Drug Administration (FDA) recognizes abstinence as an acceptable method of birth control in research studies, some pharmaceutical companies mandate the use of artificial contraceptive techniques to avoid pregnancy as a condition for participation in their studies. These requirements are unacceptable at Catholic health care institutions, leading to conflicts among institutional review boards, clinical investigators, and sponsors. Subjects may feel coerced by such mandates to adopt contraceptive techniques inconsistent with their personal situation and beliefs; women committed to celibacy or who engage exclusively in non-heterosexual activities are negatively impacted. We propose principles to insure informed consent to safeguard the rights of research subjects at Catholic institutions while mitigating this ethical conflict. At the same time, our proposal respects the interests of pharmaceutical research agencies and Catholic moral precepts, and fully abides by regulatory guidance.

AB - The Catholic Church proscribes methods of birth control other than sexual abstinence. Although the U.S. Food and Drug Administration (FDA) recognizes abstinence as an acceptable method of birth control in research studies, some pharmaceutical companies mandate the use of artificial contraceptive techniques to avoid pregnancy as a condition for participation in their studies. These requirements are unacceptable at Catholic health care institutions, leading to conflicts among institutional review boards, clinical investigators, and sponsors. Subjects may feel coerced by such mandates to adopt contraceptive techniques inconsistent with their personal situation and beliefs; women committed to celibacy or who engage exclusively in non-heterosexual activities are negatively impacted. We propose principles to insure informed consent to safeguard the rights of research subjects at Catholic institutions while mitigating this ethical conflict. At the same time, our proposal respects the interests of pharmaceutical research agencies and Catholic moral precepts, and fully abides by regulatory guidance.

UR - http://www.scopus.com/inward/record.url?scp=84862314670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862314670&partnerID=8YFLogxK

U2 - 10.1080/15265161.2012.680532

DO - 10.1080/15265161.2012.680532

M3 - Article

VL - 12

SP - 34

EP - 37

JO - American Journal of Bioethics

JF - American Journal of Bioethics

SN - 1526-5161

IS - 7

ER -